Mast Cell Tryptase Activates Peripheral Blood Eosinophils to Release Granule-Associated Enzymes
Authors:
- Paige LacyPaige Lacy
- Betty LuyBLBetty Luy
- Darryl AdamkoDADarryl Adamko
- Morley HollenbergMHMorley Hollenberg
- Dean BefusDBDean Befus
- Redwan MoqbelRMRedwan Moqbel
- 1 November 2004
- journal article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 135 (3) , 196-204
Abstract
Background: Mast cells and eosinophils are important effector cells in asthma. Understanding their interactions is essential for studying asthma pathophysiology. Inflammatory mediators released from mast cells, such as arachidonic acid metabolites, TNF and IL-5, are important in eosinophil biology. However, little is known about the effects of mast cell-specific mediators, such as tryptase, on eosinophils. Our objective was to investigate the effects of mast cell tryptase on human peripheral blood eosinophils. Methods: Peripheral blood eosinophils isolated from asthmatic individuals were activated using various concentrations of tryptase- and protease-activated receptor-2 (PAR-2)-activating peptides (PAR-2 AP). Eosinophil activation was evaluated by the release of granule mediators, superoxide release, estimation of eosinophil survival, changes in intracellular Ca2+ concentration and mitogen-activated protein kinase activation. Results: Tryptase induced the release of eosinophil peroxidase and β-hexosaminidase from peripheral blood eosinophils but had no effect on RANTES release. Eosinophils isolated from two thirds of our donors responded to tryptase, while the remainder appeared not to respond. Release of granule mediators was dependent on tryptase enzymatic activity. To identify the mechanism of eosinophil activation by tryptase, we studied the expression of PAR-2 by eosinophils and its function. Using RT-PCR, we amplified PAR-2 from eosinophils. However, flow cytometry failed to detect significant PAR-2 expression on the surface of eosinophils. The PAR-2 AP SLIGRL-NH2 did not induce eosinophil activation by any of the methods we employed. Conclusion: Our data indicate that mast cell tryptase may affect eosinophil activation status independently of PAR-2.Keywords
This publication has 37 references indexed in Scilit:
- Glycosylation and the activation of proteinase‐activated receptor 2 (PAR2) by human mast cell tryptaseBritish Journal of Pharmacology, 2001
- IL-9 expression by human eosinophils: Regulation by IL-1β and TNF-αJournal of Allergy and Clinical Immunology, 2000
- Proteinase-activated receptor-2–mediated matrix metalloproteinase-9 release from airway epithelial cellsJournal of Allergy and Clinical Immunology, 2000
- Increased vascular permeability by a specific agonist of protease‐activated receptor‐2 in rat hindpawBritish Journal of Pharmacology, 1998
- Measuring airway inflammation in asthma: Eosinophils and eosinophilic cationic protein in induced sputum compared with peripheral bloodJournal of Allergy and Clinical Immunology, 1997
- Activated Mast Cells Release Biological Activities Able to Support Eosinophil Production from Mouse Hemopoietic PrecursorsCellular Immunology, 1996
- T cells and eosinophils in the pathogenesis of asthmaImmunology Today, 1992
- Tryptase, a mediator of human mast cellsJournal of Allergy and Clinical Immunology, 1990
- Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactionsClinical & Experimental Allergy, 1985
- Superoxide Production by Eosinophils: Activation by HistamineJournal of Investigative Dermatology, 1982